Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4874-4882

  Escobar, Hernando ^a   Crockett, David K ^b   Reyes Vargas, Eduardo ^a   Baena, Andres ^c   Rockwood, Alan L ^a,c   Jensen, Peter E ^a,c   Delgado, Julio C ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B35 ANTIGEN; PEPTIDE DERIVATIVE; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; ELUTION; HLA SYSTEM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN STRUCTURE; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; CELL STRAIN K 562; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; GENETICS; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; PROTEIN MICROARRAY; VALIDATION STUDY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL LINE; CELL LINE, TRANSFORMED; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B35 ANTIGEN; HUMANS; K562 CELLS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 58149277738     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4874     Document Type: Article

References (64)

1. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512. (Pubitemid 17131093)
2. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J. Mol. Biol. 219: 277-319.
3. Falk, K., O. Rötzschke, S. Stevanović, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296. (Pubitemid 21896578)
4. Toes, R. E., A. K. Nussbaum, S. Degermann, M. Schirle, N. P. Emmerich, M. Kraft, C. Laplace, A. Zwinderman, T. P. Dick, J. Muller, et al. 2001. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12.
5. Kisselev, A. F., T. N. Akopian, K. M. Woo, and A. L. Goldberg. 1999. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes: implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem. 274: 3363-3371.
6. Cascio, P., C. Hilton, A. F. Kisselev, K. L. Rock, and A. L. Goldberg. 2001. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20: 2357-2366. (Pubitemid 32452853)
7. Saric, T., S. Chang, A. Hattori, I. York, S. Markant, K. Rock, M. Tsujimoto, and A. Goldberg. 2002. An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-1176. (Pubitemid 35476828)
8. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483. (Pubitemid 34293432)
9. York, I., S. Chang, T. Saric, J. Keys, J. Favreau, A. Goldberg, and K. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184. (Pubitemid 35469702)
10. Probst-Kepper, M., H.-J. Hecht, H. Herrmann, V. Janke, F. Ocklenburg, J. Klempnauer, B. J. van den Eynde, and S. Weiss. 2004. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. J. Immunol. 173: 5610-5616. (Pubitemid 39392148)
11. Collins, E. J., D. N. Garboczi, and D. C. Wiley. 1994. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371: 626-629.
12. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
13. Hammer, G., F. Gonzalez, E. James, H. Nolla, and N. Shastri. 2007. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat. Immunol. 8: 101-108. (Pubitemid 46242364)
14. Samino, Y., D. Lopez, S. Guil, L. Saveanu, P. M. van Endert, and M. Del Val. 2006. A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein. J. Biol. Chem. 281: 6358-6365. (Pubitemid 43847567)
15. Robinson, J., M. J. Waller, P. Parham, N. d. Groot, R. Bontrop, L. J. Kennedy, P. Stoehr, and S. G. E. Marsh. 2003. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31: 311-314.
16. Sidney, J., B. Peters, N. Frahm, C. Brander, and A. Sette. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9: 1. (Pubitemid 351283143)
17. Sette, A., and J. Sidney. 1998. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10: 478-482. (Pubitemid 28393833)
18. Bertoni, R., J. Sidney, P. Fowler, R. W. Chesnut, F. V. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100: 503-513. (Pubitemid 27340496)
19. Ressing, M. E., J. H. de Jong, R. M. Brandt, J. W. Drijfhout, W. E. Benckhuijsen, G. M. Schreuder, R. Offringa, W. M. Kast, and C. J. Melief. 1999. Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma. Eur. J. Immunol. 29: 1292-1303.
20. Doolan, D. L., S. L. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, et al. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7: 97-112.
21. Trachtenberg, E., B. Korber, C. Sollars, T. B. Kepler, P. T. Hraber, E. Hayes, R. Funkhouser, M. Fugate, J. Theiler, Y. S. Hsu, et al. 2003. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9: 928-935. (Pubitemid 36889937)
22. Matsueda, S., H. Takedatsu, T. Sasada, K. Azuma, Y. Ishihara, Y. Komohara, M. Noguchi, S. Shichijo, K. Itoh, and M. Harada. 2007. New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles. J. Immunother. 30: 274-281. (Pubitemid 46586643)
23. Minami, T., S. Matsueda, H. Takedatsu, M. Tanaka, M. Noguchi, H. Uemura, K. Itoh, and M. Harada. 2007. Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles. Cancer Immunol. Immunother. 56: 689-698. (Pubitemid 46348730)
24. Doytchinova, I. A., P. Guan, and D. R. Flower. 2004. Identifiying human MHC supertypes using bioinformatic methods. J. Immunol. 172: 4314-4323.
25. Reche, P. A., and E. L. Reinherz. 2005. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands. Nucleic Acids Res. 33: W138-W142.
26. Zhang, G. L., A. M. Khan, K. N. Srinivasan, J. T. August, and V. Brusic. 2005. MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res. 33: W172-W179.
27. Guan, P., I. A. Doytchinova, and D. R. Flower. 2003. A comparative molecular similarity indices (CoMSIA) study of peptide binding to the HLA-A3 superfamily. Bioorg. Med. Chem. 11: 2307-2311. (Pubitemid 36469243)
28. Rammensee, H. G., T. Friede, and S. Stevanoviíc. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
29. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanović. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219. (Pubitemid 30099526)
30. Dissemond, J., T. Kothen, J. Mors, T. K. Weimann, A. Lindeke, M. Goos, and S. N. Wagner. 2003. Downregulation of tapasin expression in progressive human malignant melanoma. Arch. Dermatol. Res. 295: 43-49. (Pubitemid 36791722)
31. Peaper, D. R., P. A. Wearsch, and P. Cresswell. 2005. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J. 24: 3613-3623.
32. Kageyama, S., T. Isono, H. Iwaki, Y. Wakabayashi, Y. Okada, K. Kontani, K. Yoshimura, A. Terai, Y. Arai, and T. Yoshiki. 2004. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin. Chem. 50: 857-866. (Pubitemid 38543664)
33. Delgado, J. C., A. Baena, S. Thim, and A. E. Goldfeld. 2006. Aspartic acid homozygosity at codon 57 of HLA-DQ β is associated with susceptibility to pulmonary tuberculosis in Cambodia. J. Immunol. 176: 1090-1097.
34. Purcell, A. W. 2004. Isolation and characterization of naturally processed MHCbound peptides from the surface of antigen-presenting cells. Methods Mol. Biol. 251: 291-306.
35. Gorga, J. C., V. Horejsi, D. R. Johnson, R. Raghupathy, and J. L. Strominger. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262: 16087-16094. (Pubitemid 17165204)
36. Schneider, T. D., and R. M. Stephens. 1990. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18: 6097-6100. (Pubitemid 20364672)
37. Drew, S. I., P. I. Terasaki, R. J. Billing, O. J. Bergh, J. Minowada, and E. Klein. 1977. Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood 49: 715-718.
38. + T lymphocytes in IFN-γ ELISPOT assays. J. Immunol. Methods 259: 95-110.
39. Cereb, N., and S. Y. Yang. 1996. Induction of microvariant-specific CTL lines reactive to a single amino acid mismatch in bulk cultures using a transfectant expressing a single HLA class I molecule. J. Immunol. 156: 18-26. (Pubitemid 26006943)
40. Nielsen, M., C. Lundegaard, P. Worning, S. L. Lauemoller, K. Lamberth, S. Buus, S. Brunak, and O. Lund. 2003. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 12: 1007-1017. (Pubitemid 36505435)
41. Peters, B., and A. Sette. 2005. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 6: 132. (Pubitemid 41358015)
42. Bui, H. H., J. Sidney, B. Peters, M. Sathiamurthy, A. Sinichi, K. A. Purton, B. R. Mothe, F. V. Chisari, D. I. Watkins, and A. Sette. 2005. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57: 304-314.
43. Peters, B., H. H. Bui, S. Frankild, M. Nielson, C. Lundegaard, E. Kostem, D. Basch, K. Lamberth, M. Harndahl, W. Fleri, et al. 2006. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput. Biol. 2: e65. (Pubitemid 43990673)
44. Tynan, F. E., H. H. Reid, L. Kjer-Nielsen, J. J. Miles, M. C. Wilce, L. Kostenko, N. A. Borg, N. A. Williamson, T. Beddoe, A. W. Purcell, et al. 2007. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8: 268-276.
45. Falk, K., O. Rötzschke, B. Grahovac, D. Schendel, S. Stevanović, G. Jung, and H. G. Rammensee. 1993. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 38: 161-162. (Pubitemid 23197166)
46. Steinle, A., K. Falk, O. Rotzschke, V. Gnau, S. Stevanovic, G. Jung, D. J. Schendel, and H. G. Rammensee. 1996. Motif of HLA-B*3503 peptide ligands. Immunogenetics 43: 105-107.
47. Corr, M., L. F. Boyd, E. A. Padlan, and D. H. Margulies. 1993. H-2Dd exploits a four residue peptide binding motif. J. Exp. Med. 178: 1877-1892. (Pubitemid 2021437)
48. Arnett, K. L., W. Huang, N. M. Valiante, L. D. Barber, and P. Parham. 1998. The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells. Immunogenetics 48: 56-61.
49. DiBrino, M., K. C. Parker, J. Shiloach, M. Knierman, J. Lukszo, R. V. Turner, W. E. Biddison, and J. E. Coligan. 1993. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Natl. Acad. Sci. USA 90: 1508-1512. (Pubitemid 23058202)
50. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the alpha2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213. (Pubitemid 126349697)
51. Menssen, R., P. Orth, A. Ziegler, and W. Saenger. 1999. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. J. Mol. Biol. 285: 645-653. (Pubitemid 29041798)
52. Falk, K., O. Rotzschke, M. Takiguchi, V. Gnau, S. Stevanovic, G. Jung, and H. G. Rammensee. 1995. Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 41: 162-164.
53. Falk, K., O. Rotzschke, M. Takiguchi, B. Grahovac, V. Gnau, S. Stevanovic, G. Jung, and H. G. Rammensee. 1994. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40: 238-241. (Pubitemid 24217868)
54. Fortier, M. H., E. Caron, M. P. Hardy, G. Voisin, S. Lemieux, C. Perreault, and P. Thibault. 2008. The MHC class I peptide repertoire is molded by the transcriptome. J. Exp. Med. 205: 595-610.
55. Prilliman, K. R., K. W. Jackson, M. Lindsey, J. Wang, D. Crawford, and W. H. Hildebrand. 1999. HLA-B15 peptide ligands are preferentially anchored at their C termini. J. Immunol. 162: 7277-7284.
56. Hickman, H. D., A. D. Luis, R. Buchli, S. R. Few, M. Sathiamurthy, R. S. Vangundy, C. F. Giberson, and W. H. Hildebrand. 2004. Toward a defi- nition of self: proteomic evaluation of the class I peptide repertoire. J. Immunol. 172: 2944-2952.
57. Thammavongsa, V., G. Raghuraman, T. M. Filzen, K. L. Collins, and M. Raghavan. 2006. HLA-B44 polymorphisms at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy. J. Immunol. 177: 3150-3161. (Pubitemid 44277833)
58. Benham, A. M., M. Gromme, and J. Neefjes. 1998. Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J. Immunol. 161: 83-89.
59. Montserrat, V., B. Galocha, M. Marcilla, M. Vazquez, and J. A. Lopez de Castro. 2006. HLA-B*2704, an allotype associated with ankylosing spondylitis, is critically dependent on transporter associated with antigen processing and relatively independent of tapasin and immunoproteasome for maturation, surface expression, and T cell recognition: relationship to B*2705 and B*2706. J. Immunol. 177: 7015-7023. (Pubitemid 44715068)
60. Neisig, A., R. Wubbolts, X. Zang, C. Melief, and J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156: 3196-3206. (Pubitemid 26123533)
61. Park, B., S. Lee, E. Kim, and K. Ahn. 2003. A single polymorphic residue within the peptide-binding cleft of MHC class I molecules determines spectrum of tapasin dependence. J. Immunol. 170: 961-968. (Pubitemid 36070550)
62. Zernich, D., A. W. Purcell, W. A. Macdonald, L. Kjer-Nielsen, L. K. Ely, N. Laham, T. Crockford, N. A. Mifsud, M. Bharadwaj, L. Chang, et al. 2004. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J. Exp. Med. 200: 13-24. (Pubitemid 38924724)
63. Gao, X., G. W. Nelson, P. Karacki, M. P. Martin, J. Phair, R. Kaslow, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, et al. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344: 1668-1675. (Pubitemid 32479964)
64. Kunisawa, J., and N. Shastri. 2006. Hsp90α chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 24: 523-534. (Pubitemid 43728158)